Xiangyu Medical Co. Ltd. A (688626) — Capital Reinvestment Ratio
Xiangyu Medical Co. Ltd. A (688626) has a Capital Reinvestment Ratio of 3.23x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥18.05 Million) in capital expenditures (CN¥58.35 Million). See how leveraged is Xiangyu Medical Co. Ltd. A's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiangyu Medical Co. Ltd. A Capital Reinvestment Ratio (2017–2024)
This chart tracks Xiangyu Medical Co. Ltd. A's Capital Reinvestment Ratio across 8 annual periods. Check Xiangyu Medical Co. Ltd. A cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xiangyu Medical Co. Ltd. A (2017–2024)
Year-by-year Capital Reinvestment Ratio for Xiangyu Medical Co. Ltd. A from 2017 to 2024. For live market cap and broader valuation context, see 688626 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.46x | CN¥178.59 Million | CN¥438.89 Million | ▲ +16.9% |
| 2023 | 2.10x | CN¥227.91 Million | CN¥479.26 Million | ▲ +93.3% |
| 2022 | 1.09x | CN¥186.70 Million | CN¥203.07 Million | ▲ +34.7% |
| 2021 | 0.81x | CN¥165.88 Million | CN¥133.91 Million | ▲ +25.0% |
| 2020 | 0.65x | CN¥216.40 Million | CN¥139.71 Million | ▲ +377.9% |
| 2019 | 0.14x | CN¥155.94 Million | CN¥21.07 Million | ▲ +42.9% |
| 2018 | 0.09x | CN¥74.20 Million | CN¥7.02 Million | ▼ -62.2% |
| 2017 | 0.25x | CN¥59.31 Million | CN¥14.84 Million | — |